White v. Commissioner of Social Security

District Court, S.D. Ohio·Decided April 20, 2020·No. 2:19-cv-03982·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO EASTERN DIVISION

PATRICIA J. WHITE,

Plaintiff, v. Civil Action 2:19-cv-3982 Judge Michael H. Watson Magistrate Judge Kimberly A. Jolson

COMMISSIONER OF SOCIAL SECURITY,

Defendant.

REPORT AND RECOMMENDATION Plaintiff, Patricia J. White, brings this action under 42 U.S.C. § 405(g) seeking review of a final decision of the Commissioner of Social Security (“Commissioner”) denying her applications for Disability Insurance Benefits (“DIB”) and Supplemental Security Income Benefits (“SSI”). For the reasons set forth below, it is RECOMMENDED that the Court REVERSE the Commissioner’s non-disability finding and REMAND this case to the Commissioner and Administrative Law Judge under Sentence Four of § 405(g). I. BACKGROUND

Plaintiff filed her applications for DIB and SSI in March 2012, alleging that she was disabled beginning June 1, 2001. (Tr. 313–27). After her application was denied initially and on reconsideration, the Administrative Law Judge (the “ALJ”) held a hearing on May 27, 2014. (Tr. 98–122). On June 24, 2014, the ALJ issued a decision denying Plaintiff’s application for benefits. (Tr. 77–97). The Appeals Council denied Plaintiff’s request for review, making the ALJ’s decision the final decision of the Commissioner. (Tr. 1–6). Plaintiff then filed a case in this Court. (See Southern District of Ohio, 2:15-cv-3055). On June 28, 2016, Judge George C. Smith accepted a joint motion to remand the case back to the administrative level. (Tr. 1749). A second administrative hearing was held on November 13, 2017, (Tr. 1675–1722), and a third hearing was held on June 21, 2018, (Tr. 1655–1674). On August 3, 2018, the ALJ issued an unfavorable decision. (Tr. 1615–1654). In lieu of appealing to the Appeals Council, Plaintiff filed the instant case on September

10, 2019 (Doc. 1). This matter is now ripe for resolution. (See Docs. 6, 9, 10, 11). A. Relevant Medical Evidence

Because Plaintiff’s Statement of Errors pertains only to her vision issues, the Undersigned limits her discussion to the same. In July 2001, Plaintiff developed blurred vision in her right eye, which affected her central vision and resulted in discomfort with eye movements. (See Tr. 525– 26). She was referred to neuro-ophthalmologist Dr. Steven Katz, who examined Plaintiff on August 11, 2001. (Tr. 485–87). He noted that Plaintiff had signs of lymphadenopathy on her imaging studies, which were suggestive of sarcoidosis. (Tr. 488). Dr. Katz also noted that Plaintiff’s visual acuity was significantly diminished in her right eye but that she retained 20/20 vision in her left eye. (Id.). He noted that her work-up was unremarkable for infectious or inflammatory conditions that were typically associated with this disorder and found it was likely that Plaintiff had the coexisting autoimmune disorder of sarcoidosis. (Id.). He administered a Kenalog injection to treat her neuroretinitis condition on August 21, 2001. (Tr. 486–87). And mediastinoscopy results, dated November 8, 2001, confirmed the diagnosis of pulmonary sarcoidosis. (Tr. 520–21). In a May 2003 correspondence, Dr. Katz summarized his treatment history and clinical findings in Plaintiff’s case. (Tr. 611–613). He noted that Plaintiff was diagnosed with neuroretinitis of the right eye with some optic atrophy despite injections. (Id.). At that time, vision testing showed that she was essentially blind in the right eye with no more than light perception. (Id.). It appears from the record that, over the next eight or nine years, Plaintiff did not regularly receive treatment for her vision problems. In July 2012, neurologist Dr. David Arnold evaluated Plaintiff’s neuromuscular symptoms. (Tr. 1256–57). At that time, her right eye ptosis issues were attributed to ocular myasthenia rather

than sarcoidosis. (Id.). She underwent single fiber electromyelogram nerve conduction studies, which did not reveal any neuromuscular transmission defect. (Id.). Dr. Arnold then ordered updated laboratory studies to determine if myasthenia gravis should be treated with immune- modulating agents. (Id.). On November 21, 2012, Drs. E. Bakri and R. Panara performed a consultative neuromuscular evaluation of Plaintiff regarding her ocular myasthenia condition. (Tr. 1450–52). Plaintiff reported that she had experienced ptosis and double vision in the past that had improved over time and that she no longer required treatment for persistent ocular symptoms. (Id.). She reported, however, that she experiences problems with ptosis, light sensitivity, and eye pain when

she works too long at the computer or watches television for a long time. (Id.). Records from August 2014 note Plaintiff’s complaints of problems with ptosis, cluster headaches, unilateral eye pain, and lacrimation. (Tr. 2624). On November 8, 2016, Dr. Nicholas Rogers performed a consultative vision examination. (Tr. 3165–66). Test results revealed that Plaintiff’s best-corrected vision in her left eye was 20/20. (Tr. 3165). But she still had significant right-eye vision deficits. (Tr. 3165–66). On November 18, 2016, Dr. David Hirsh also performed an ophthalmological evaluation. (Tr. 3305–09). Plaintiff told Dr. Hirsh that she was concerned about her vision in her left eye, which she reported had begun to decline over the last six to eight months. (Tr. 3307). Dr. Hirsh’s diagnostic impression was nonarthritic anterior ischemic optic neuropathy. (Tr. 3309.). B. The ALJ’s Decision

Free access — add to your briefcase to read the full text and ask questions with AI

White v. Commissioner of Social Security, (S.D. Ohio 2020).

White v. Commissioner of Social Security (White v. Commissioner of Social Security) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related